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The effects of the left-shifting, anti-sickling compound BWl2C (5-(2-formyl-3-hydroxyphenoxy)pentanoic 
acid) on the oxygen saturation curve of whole chicken blood and the isolated major (AII) and minor (AI) 
components of chicken hemoglobin have been studied. The results upport he postulated major binding 
mode for BWl2C to human hemoglobin ofbridging between the a-chain terminal amino groups in the oxy 
conformation with an important hydrophobic component contributed mainly by Pro 77a residues. Inchick- 
en AI1 (Pro 77a+Ser) BWI2C still left-shifts at high concentrations but its potency is greatly reduced (at 
least lo-fold). In chicken AI (Pro 77a+Ser and Val la+Met) BWl2C is a right-shifter with a potency com- 
parable to that of 2,3-diphosphoglycerate suggesting that binding at the /I-chain termini in the deoxy confor- 
mation is now dominant with a-chain binding no longer significant. 
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1. INTRODUCTION 
BW12C, 5-(2-formyl-3-hydroxyphenoxy)pen- 
tanoic acid, is a potent left-shifter of the oxygen 
saturation curve of human hemoglobin (HbA) and 
an inhibitor of the sickling of erythrocytes from 
homozygous sickle cell blood in vitro at reduced 
oxygen pressures [1,2]. The compound was de- 
signed to bind preferentially to the oxy conforma- 
tion of HbA at the a-chain terminal amino region 
forming a Schiff base interaction with one amino 
group (Val la) and an ionic interaction with the 
other. In addition, modelling indicated that the 
tetramethylene side-chain could form a favorable 
hydrophobic interaction with hydrophobic 
residues at this site particularly Pro 77cu and the 
potency of BW12C suggests that this is the case. 
Preferential interaction of BWl2C with the CY- 
terminal amino groups in the oxy conformation 
has been established [3] but in order to provide 
evidence for the involvement of the Pro 77~ 
residues the literature [4,5] was searched for mu- 
tant human hemoglobins or hemoglobins from 
alternative species with suitable sequence dif- 
ferences. Studies of the effects of different 
hemoglobins on the action of a series of right- 
shifting compounds previously provided evidence 
for binding at the&chain terminal amino region as 
postulated [6]. No mutant human hemoglobins 
containing suitable modifications in the vicinity of 
the a-chain termini were found but chicken 
hemoglobins appeared interesting. Chicken 
erythrocytes contain two main hemoglobin types, 
chicken major (AII, -75%) and chicken minor 
(AI, -20%) [7]. The major component has the Pro 
77cu groups replaced by serine residues [8] and the 
minor component in addition has the Val la 
groups replaced by methionine residues [9]. The ef- 
fects of BWl2C on chicken blood and isolated 
chicken hemoglobins are reported here. 
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2. MATERIALS AND METHODS 
Chicken blood from freshly killed White 
Leghorn chickens was collected into heparinised 
tubes. The hematocrit was determined as 30% 
which is lower than for normal human blood 
(43%). A mixture of chicken hemoglobins was 
prepared using the method of Paterson et al. [lo]. 
This was then dialysed against 10 mM Hepes 
(Hopkins and Williams), pH 7.0, and applied to a 
carboxymethyl-cellulose column (CM-32, What- 
man) equilibrated in the same buffer. Con- 
taminating proteins were removed by washing with 
running buffer followed by 10 mM Hepes at pH 
7.5 and the minor and major chicken hemoglobins 
were eluted by 10 mM Hepes, pH 8.0, and 10 mM 
Hepes, pH 8.0, plus 50 mM NaCl, respectively. 
Organic phosphates were removed by passage 
down a Sephadex G-25 column equilibrated in 
0.1 M NaCl, 1 mM Hepes, pH 7.2. Phosphate 
contents were determined [lo] as 0.07 and 
0.13 mol total phosphate per mol hemoglobin for 
minor and major components, respectively. In- 
ositol hexaphosphate was purchased as the sodium 
salt (BDH) and used as supplied. BW12C was 
prepared by Dr G. Kneen as described in published 
UK patent specification no.2053218, Kneen, G. 
(The Wellcome Foundation Ltd). 
Oxygen saturation curve measurements on 
whole blood were performed in the association 
mode at 37°C using a Hem-O-Scan (Aminco, 
Silver Springs, MD) as described in [2]. Saturation 
curves for dilute hemoglobin solutions (23 /IM on 
a tetramer basis, 5.4 ml of total solution 35 mM 
KCl, 100 mM Hepes; pH 7.4) were measured in the 
dissociation mode using a Hemox Analyzer (TCS 
Medical Products Division, Southampton, PA) as 
in [2]. 
3. RESULTS 
The effect of a range of concentrations of 
BW12C on the oxygen association curve of fresh 
chicken blood is shown in fig.la, and fig.lb gives 
corresponding curves for normal human blood for 
comparison [2]. As noted previously [2] the high 
affinity of BW12C for human hemoglobin results 
in essentially stoichiometric binding in whole 
blood, and at lower doses the curves show a 
biphasic appearance due to the two functionally 
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Fig. 1. Effect of BW12C on the oxygen association curve 
for fresh whole chicken (a) and human (b) blood. 
Concentrations of BW12C (mM) frdm right to left: (a) 
0, 1.5, 3, 4.5; (b) 0, 2, 4, 6, 8, 10. 
different forms of hemoglobin present, i.e. left- 
shifted, BW 12C-reacted hemoglobin and 
unreacted hemoglobin. In human blood, 10 mM 
BW12C is required to react fully with the 
hemoglobin representing a binding stoichiometry 
of -4: 1 and at this concentration the curve is no 
longer biphasic. In chicken blood the biphasic 
nature of the curves is even more pronounced due 
to the higher initial PSO. At the reduced hematocrit 
of the sample of chicken blood used (30%) a max- 
imal effect of BW12C would be expected at 
-7 mM but in fact 4.5 mM BW12C produces a 
maximal effect with 6 and 9 mM giving the same 
curve. Also, the curve is still biphasic and appears 
to correspond to -70% of a left-shifted compo- 
nent and -30% of a component which is not left- 
shifted. 
These proportions show an obvious cor- 
respondence with the amounts of the major and 
minor hemoglobin components of chicken blood 
[7] and these were therefore isolated and stripped 
of phosphate for further study. The effects of 
BW12C on the oxygen dissociation curves of dilute 
solutions of chicken major and minor hemoglobins 
are shown in fig.2a and b, respectively. As ex- 
pected from the sequence change Pro 77a+Ser, 
BW12C is less potent in its action on chicken ma- 
jor compared with human hemoglobin. 0.1 mM 
BW12C is sufficient to left-shift fully in human 
hemoglobin [2] whereas at this dose BW12C is only 
starting to produce effects in chicken major. 
Qualitative differences are also apparent, however, 
since at lower doses BW12C causes a right-shift at 
the top of the curve with chicken major, and a full 
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Fig.2. Effect of BW12C on the oxygen dissociation 
curve of dilute (23 PM) solutions of (a) chicken major 
hemoglobin and (b) chicken minor hemoglobin. 
Concentrations of BW12C (mM) - a: (0) 0, (0) 0.1, (m) 
0.2, (0) 0.35, (A) 1.0; b: (0) 0, (0) 0.1, (m) 0.2, (0) 
0.5. T = 37”C, 100 mM Hepes buffer, pH 7.4, 35 mM 
KCI. The data were recorded as continuous curves. The 
symbols are added merely as an aid to identification. 
left-shift is only produced for higher doses. The 
different potencies for the interaction of BW12C 
with human and chicken major are illustrated in 
fig.3 which plots the difference in log PSO between 
control and treated curves against log dose. In this 
representation BW12C appears about an order of 
magnitude less potent on chicken major compared 
with human, but the difference may be con- 
siderably larger since at the lower doses of BW12C 
used for human hemoglobin the free concentra- 
tions will be much lower than the total dose plotted 
in fig.3 [2]. 
The whole blood curves (fig.la) suggested that 
BW12C might be without effect on chicken minor 
hemoglobin. In fact fig.2b shows that considerable 
right-shifting activity is observed. Fig.3 compares 
the right-shifting effect of BW12C in chicken 
minor with that of 2,3-diphosphoglycerate in 
human hemoglobin measured under the same con- 
ditions [l l] and shows that the potencies are com- 
parable. The fact that the top ends of the whole 
blood curves were not right-shifted may be ex- 
plained if BW12C is binding to the &terminal 
amino groups in the deoxy conformation, since the 
presence of the very tightly bound natural effector, 
inositol pentaphosphate, in chicken blood would 
preclude any additional shift by BW12C. In agree- 
ment with this the E’s0 for chicken minor 
hemoglobin in the presence of 0.1 mM inositol 
hexaphosphate was found to be the same 
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Fig.3. Plot of Alog& (log& treated minus log&~ 
control) against log dose for (e) BW12C with chicken 
major, (0) BW12C with chicken minor, (w) BW12C 
with human, ( q ) 2,3_diphosphoglycerate with human. 
Conditions as in fig.2. 
(33 mmHg) in the absence or presence of 0.5 mM 
BW12C. 
4. DISCUSSION 
Although BW12C was designed to bind 
preferentially at the a-chain terminal amino region 
in the oxy conformation of human hemoglobin, 
binding to CY- and &chain terminal amino groups 
in the oxy and deoxy conformations via Schiff base 
formation has been observed [3]. In addition, 
binding to the c-amino groups of the many lysine 
residues is likely, but extensive studies with 
pyridoxal derivatives have indicated a distinct 
preference for Schiff base formation at the amino 
termini [ 12-141 due presumably to the more 
favorable pK values for these groups compared 
with lysine residues [15]. Three distinct com- 
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ponents of the mechanism for the left-shifting ef- 
fect of BW12C in whole blood may therefore be 
envisaged: (i) overall preferential binding at the LY- 
chain terminal amino region in the oxy conforma- 
tion; (ii) rupture of the anion-mediated a-chain 
amino termini salt bridges with the guanidinium 
groups of the carboxy terminal arginine residues of 
the opposite a-chains in the deoxy conformation 
[16] on Schiff base formation, leading to a direct 
increase in oxygen affinity of the deoxy conforma- 
tion and reduction in cooperativity; (iii) direct 
competition for binding at the P-chain terminal 
region in the deoxy conformation with 
2,3_diphosphoglycerate. 
The present results provide supportive evidence 
for the postulated binding mode at the a-chain ter- 
minal amino region in the oxy conformation. 
Chicken hemoglobins, of course, contain many 
differences in sequence from human hemoglobin, 
but the replacement of Pro 77cy by serine seems the 
likely cause for the loss of potency of BW12C in 
chicken major since there are no other significant 
changes in sequence from human hemoglobin in 
this region. The results indicate that the loss of this 
hydrophobic residue leads to a reduction in 
binding at the a-chain terminus in the oxy confor- 
mation with a consequently greater importance of 
other binding modes. In fact, the shapes of the 
curves may be explained if binding at the P-chains 
in the deoxy conformation predominates at low 
concentrations leading to the right-shift at the PSO, 
but at higher concentrations binding to the Q- 
chains in the deoxy conformation becomes domi- 
nant resulting in a left-shift due to the rupture of 
salt bridges. 
The right-shifted curves with chicken minor 
hemoglobin suggest hat binding at the &terminus 
in the deoxy conformation is now the dominant 
binding mode, and reaction at this site is supported 
by the competition for binding with inositol hex- 
aphosphate. The sequences of the&chains of both 
forms of chicken hemoglobin are apparently iden- 
tical [17,18], and the difference between the effects 
of BW12C on the major and minor components 
must therefore depend on their different a-chain 
sequences. The most obvious difference in the (Y- 
chain terminal amino region is the replacement Val 
lcu+Met, and this would be expected to disfavor 
binding at this locus since model studies of the 
Schiff base formation of pyridoxal and amino 
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acids [19] showed an approx. 2-fold increase in 
binding constants for the amino acids valine and 
isoleucine, which are branched on the P-carbon 
atom, compared with norvaline and leucine. 
There is a possible additional effect, however. 
Ser 138cu in human hemoglobin lies fairly close 
(O-N distance 6.7 A 120,211) to the terminal 
amino group of the opposite cr-chain in the deoxy 
conformation. In chicken major this is alanine, 
which should not cause any marked change, but in 
chicken minor it is a glutamic acid. The carbox- 
ylate group of this glutamic acid residue would be 
ideally positioned to form a salt bridge with the 
terminal amino group itself, particularly at the 
rather low KC1 concentration (35 mM) used in the 
present experiments which would not favor the 
anion-mediated salt bridge between the terminal 
amino and the carboxy terminal arginine observed 
at high ionic strength [16]. This salt bridge forma- 
tion with Glu 138cu would then tend to block the 
reaction of the a-chain terminal amino groups with 
BW12C leaving binding at the p-terminus as the 
only remaining binding mode. In fact, precisely the 
opposite effects, albeit less pronounced, were 
observed in the reaction of a series of right-shifting 
compounds designed to bind preferentially at the 
p-terminus [a]. Here, the blocked &terminal 
amino groups in fetal minor (HbFr), glucosylated 
hemoglobin (HbArc) and the mutant Hb Raleigh 
changed right-shifting activity into left-shifts for a 
dialdehyde compound binding largely by Schiff 
base formation. 
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